High-dose or low-dose cisplatin concurrent with radiotherapy in locally advanced head and neck squamous cell cancer.
Chia-Lun ChangKevin Sheng-Po YuanSzu-Yuan WuPublished in: Head & neck (2017)
High-dose concurrent CRT can reduce the incidence of death in patients with stage III or IV HNSCC.